Oglesby A, et al. Patient-reported outcomes after switching to a two-drug regimen of dolutegravir + rilpivirine: Week 100 results from the SWORD-1 and SWORD-2 studies. Abstract P101. HIV/Drug Therapy Glasgow 2018.
Niet-invasieve screening op maagkanker: S. anginosus en S. constellatus
sep 2022 | Maag-darm-leveroncologie